Cargando…

Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study

BACKGROUND: Optimal debulking surgery is postulated to be useful in survival of ovarian cancer patients. Some studies highlighted the possible role of bowel surgery in this topic. We wanted to evaluate the role of bowel involvement in patients with advanced epithelial ovarian cancer who underwent op...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giorda, Giorgio, Gadducci, Angiolo, Lucia, Emilio, Sorio, Roberto, Bounous, Valentina E, Sopracordevole, Francesco, Tinelli, Andrea, Baldassarre, Gustavo, Campagnutta, Elio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100746/ https://www.ncbi.nlm.nih.gov/pubmed/25328074 http://dx.doi.org/10.1186/1757-2215-7-72

Ejemplares similares

Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research
por: Gadducci, Angiolo, et al.
Publicado: (2020)

Trabectedin and lurbinectedin: Mechanisms of action, clinical impact, and future perspectives in uterine and soft tissue sarcoma, ovarian carcinoma, and endometrial carcinoma
por: Gadducci, Angiolo, et al.
Publicado: (2022)

Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery
por: Eoh, Kyung Jin, et al.
Publicado: (2016)

Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis
por: Garziera, Marica, et al.
Publicado: (2015)

Bevacizumab or PARP-Inhibitors Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis
por: Bartoletti, Michele, et al.
Publicado: (2020)

Pharmacological Treatment of Patients with Metastatic, Recurrent or Persistent Cervical Cancer Not Amenable by Surgery or Radiotherapy: State of Art and Perspectives of Clinical Research
por: Gadducci, Angiolo, et al.
Publicado: (2020)

Pharmacological Treatment of Advanced, Persistent or Metastatic Endometrial Cancer: State of the Art and Perspectives of Clinical Research for the Special Issue “Diagnosis and Management of Endometrial Cancer”
por: Gadducci, Angiolo, et al.
Publicado: (2021)

Perivascular epithelioid cell tumors (PEComa) of the female genital tract: A challenging question for gynaecologic oncologist and pathologist
por: Gadducci, Angiolo, et al.
Publicado: (2020)

Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
por: Gadducci, Angiolo, et al.
Publicado: (2019)

Paraneoplastic cerebellar degeneration associated with ovarian cancer
por: RUSSO, ALESSIA ERIKA, et al.
Publicado: (2013)

Angiosarcomaafteradjuvantradiotherapy in high-risksquamouscell carcinoma of the vulva: a case report
por: Laliscia, Concetta, et al.
Publicado: (2020)

A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab
por: Tognarelli, Alessio, et al.
Publicado: (2019)

Prognostic Factors Research in Breast Cancer Patients: New Paths
por: Susini, Tommaso, et al.
Publicado: (2022)

Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: analysis of prognostic factors and survival
por: Biglia, Nicoletta, et al.
Publicado: (2016)

CDK6 protects epithelial ovarian cancer from platinum‐induced death via FOXO3 regulation
por: Dall'Acqua, Alessandra, et al.
Publicado: (2017)

Laser CO(2) treatment for vulvar lymphedema secondary to gynecological cancer therapy: A report of two cases and review of the literature
por: SOPRACORDEVOLE, FRANCESCO, et al.
Publicado: (2015)

Extramammary Paget disease of the vulva: immunohistochemical analysis of neoangiogenesis and epithelial-mesenchymal transition markers expression
por: Alessandrini, Lara, et al.
Publicado: (2018)

Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives
por: Dall’Acqua, Alessandra, et al.
Publicado: (2021)

What sampling device is the most appropriate for vaginal vault cytology in gynaecological cancer follow up?
por: Lino, Del Pup, et al.
Publicado: (2012)

What sampling device is the most appropriate for vaginal vault cytology in gynaecological cancer follow up?
por: Lino, Del Pup, et al.
Publicado: (2012)

Conservative treatment of coexisting microinvasive squamous and adenocarcinoma of the cervix: report of two cases and literature review
por: Sopracordevole, Francesco, et al.
Publicado: (2016)

Abnormal Pap Smear and Diagnosis of High-Grade Vaginal Intraepithelial Neoplasia: A Retrospective Cohort Study
por: Sopracordevole, Francesco, et al.
Publicado: (2015)

Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
por: Viel, A., et al.
Publicado: (1992)

TIMP-1 Is Overexpressed and Secreted by Platinum Resistant Epithelial Ovarian Cancer Cells
por: Sonego, Maura, et al.
Publicado: (2019)

Primary intestinal-type adenocarcinoma of the vulva. A case report and review of the literature
por: Sopracordevole, Francesco, et al.
Publicado: (2023)

New Challenges in Tumor Mutation Heterogeneity in Advanced Ovarian Cancer by a Targeted Next-Generation Sequencing (NGS) Approach
por: Garziera, Marica, et al.
Publicado: (2019)

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer.
por: Scambia, G., et al.
Publicado: (1995)

Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
por: Fabbi, Marina, et al.
Publicado: (2022)

Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells
por: Sonego, Maura, et al.
Publicado: (2017)

Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?
por: Laliscia, Concetta, et al.
Publicado: (2016)

Atypical Endometrial Hyperplasia and Unexpected Cancers at Final Histology: A Study on Endometrial Sampling Methods and Risk Factors
por: Giannella, Luca, et al.
Publicado: (2020)

Clinical, Pathological, and Prognostic Features of Male Breast Cancer: A Multicenter Study
por: Accomasso, Francesca, et al.
Publicado: (2023)

Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS)
por: Garziera, Marica, et al.
Publicado: (2018)

Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
por: Lorusso, Domenica, et al.
Publicado: (2022)

Corrigendum: Optimizing the use of lenvatinib in combination with pembrolizumab in patients with advanced endometrial carcinoma
por: Lorusso, Domenica, et al.
Publicado: (2023)

Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)
por: Garziera, Marica, et al.
Publicado: (2019)

Laparoscopic Management of Ovarian Pregnancy
por: Tinelli, Andrea, et al.
Publicado: (2008)

Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case report
por: Puppa, Giacomo, et al.
Publicado: (2007)

A new role for IDH1 in the control of ovarian cancer cells metabolism and senescence
por: Sonego, Maura, et al.
Publicado: (2020)

Extra-Nuclear Signaling of Progesterone Receptor to Breast Cancer Cell Movement and Invasion through the Actin Cytoskeleton
por: Fu, Xiao-Dong, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_bnjldtj305scpvue4t651h45oc